Literature DB >> 7506628

Comparative study of selective alpha 1-adrenoceptor blockade versus surgery in the treatment of prostatic obstruction.

C R Chapple1, J G Noble, E J Milroy.   

Abstract

Alternative treatments for benign prostatic hyperplasia (BPH) are the source of much discussion at present. Pharmacotherapy has been demonstrated to have an increasing role in the management of BPH. This study contrasts the efficacy of the selective alpha antagonist prazosin as compared with placebo and the subsequent improvements seen following surgical treatment. Whilst selective alpha blockade has undoubted therapeutic efficacy the improvement in symptom scores and the objective urodynamic measure of the flow rate are not as marked as those seen following surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506628     DOI: 10.1111/j.1464-410x.1993.tb16275.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  A pharmacoeconomic analysis of patients with symptoms of benign prostatic hyperplasia.

Authors:  P C Cockrum; S F Finder; A J Ries; R P Potyk
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 2.  Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Authors:  L M Eri; K J Tveter
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 3.  The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.

Authors:  G M Oades; J D Eaton; R S Kirby
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

Review 4.  Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.

Authors:  Cheng-Ling Lee; Hann-Chorng Kuo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.